12:00 AM
Sep 13, 1999
 |  BC Week In Review  |  Company News  |  Other News

Bioglan dermatology news

BGP sold its 50 percent interest in diagnostic imaging company Goldham Bioglan Pharma GmbH (Zusmarshausen, Germany) for DM6.9 million ($3.8 million)...

Read the full 81 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >